MACROGENICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
MACROGENICS, INC. (MGNX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $5.51 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-09
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $5.51M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $5.18M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $4.00M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $5.00M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $5.51M 10-K · filed 2026-03-09 |
| 2024-12-31 | $5.18M 10-K · filed 2025-03-20 |
| 2023-12-31 | $4.00M 10-K · filed 2024-03-07 |
| 2022-12-31 | $5.00M 10-K · filed 2023-03-15 |
| 2021-12-31 | $6.94M 10-K · filed 2022-02-24 |
| 2020-12-31 | $6.73M 10-K · filed 2021-02-25 |
| 2019-12-31 | $5.91M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |